Trading-Stocks.de

Healthcare | Drugs - Generic | USA

Zoetis (ZTS) Tops Q1 Earnings Estimates

Zoetis (ZTS) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 11.39%. A quarter ago, it was expected that this animal health company would post earnings of $0.77 per share when it actually produced earnings of $0.79, delivering a surprise of 2.60%.

...

https://finance.yahoo.com/news/zoetis-zt...12203.html

Animal-Health Stock Jumps To Record High As Spending On Fido Grows

Sales to pet owners climbed markedly. Spending on animals in the U.S. grew 23% and companion animal revenue jumped 21% internationally, on an operational basis. Meanwhile, sales of drugs for livestock — such as antibiotics — grew 3% in the U.S. and 4% operationally outside the U.S.

...

During the second quarter ended June 30, Zoetis earnings were 90 cents per share, minus certain items, on $1.55 billion in sales. On a year-over-year basis, Zoetis earnings climbed 17% and sales advanced 9%, or 14% operationally, the animal-health company said in a news release.

...

https://www.investors.com/news/technolog...yptr=yahoo

Zoetis (ZTS) Q4 Earnings and Revenues Beat Estimates

Zoetis (ZTS) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this animal health company would post earnings of $0.89 per share when it actually produced earnings of $0.94, delivering a surprise of 5.62%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Zoetis, which belongs to the Zacks Medical - Drugs industry, posted revenues of $1.67 billion for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 2.12%. This compares to year-ago revenues of $1.56 billion.


...

https://finance.yahoo.com/news/zoetis-zt...01660.html